AAAAAA
Results:
1-7
|
Results: 7
Authors:
Tintignac, LA
Leibovitch, MP
Leibovitch, SA
Citation: La. Tintignac et al., New insight into MyoD regulation: involvement in rhabdomyosarcoma pathway?, B CANCER, 88(6), 2001, pp. 545-548
Authors:
Reynaud, EG
Guillier, M
Leibovitch, MP
Leibovitch, SA
Citation: Eg. Reynaud et al., Dimerization of the amino terminal domain of p57(Kip2) inhibits cyclin D1-Cdk4 kinase activity, ONCOGENE, 19(9), 2000, pp. 1147-1152
Authors:
Reynaud, EG
Leibovitch, MP
Tintignac, LAJ
Pelpel, K
Guillier, M
Leibovitch, SA
Citation: Eg. Reynaud et al., Stabilization of MyoD by direct binding to p57(Kip2), J BIOL CHEM, 275(25), 2000, pp. 18767-18776
Authors:
Pelpel, K
Leibovitch, MP
Fernandez, A
Leibovitch, SA
Citation: K. Pelpel et al., Mutation of MyoD-Ser237 abolishes its up-regulation by c-Mos, FEBS LETTER, 474(2-3), 2000, pp. 233-237
Authors:
Tintignac, LA
Leibovitch, MP
Kitzmann, M
Fernandez, A
Ducommun, B
Meijer, L
Leibovitch, SA
Citation: La. Tintignac et al., Cyclin E-Cdk2 phosphorylation promotes late G1-phase degradation of MyoD in muscle cells, EXP CELL RE, 259(1), 2000, pp. 300-307
Authors:
Reynaud, EG
Pelpel, K
Guillier, M
Leibovitch, MP
Leibovitch, SA
Citation: Eg. Reynaud et al., p57(Kip2) stabilizes the MyoD protein by inhibiting cyclin E-Cdk2 kinase activity in growing myoblasts, MOL CELL B, 19(11), 1999, pp. 7621-7629
Authors:
Solhonne, B
Lenormand, JL
Pelpel, K
Leibovitch, MP
Leibovitch, SA
Citation: B. Solhonne et al., MyoD binds to Mos and inhibits the Mos/MAP kinase pathway, FEBS LETTER, 461(1-2), 1999, pp. 107-110
Risultati:
1-7
|